Sage Therapeutics, Inc. (SAGE)
Latest SAGE Insider Trades
About Sage Therapeutics, Inc. (SAGE)
Sage Therapeutics, Inc. files with the SEC under CIK 0001597553 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
90-Day SEC Filing Activity
No Form 4 activity for SAGE in the last 90 days.
SAGE Insider Transactions (Form 4)
3516 Form 4 filings on record, the earliest from Nov 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Michael F. Cola | Derivative | Stock Option (Right to Buy) | 21,500 | - |
SAGE Insider Trading - FAQ
What is the latest insider trade for SAGE?
Sage Therapeutics, Inc. (SAGE) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-07-31. The full record for SAGE runs to 16 Form 4 filings, the earliest from 2024-11-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying SAGE stock?
No insider purchases of SAGE were filed in the last 90 days.
How many insiders are selling SAGE stock?
No insider sales of SAGE were filed in the last 90 days.
Where can I see SAGE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks SAGE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow SAGE insider buys?
Create a free InsiderAlpha account and press Watch on this page to add SAGE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Michael F. Cola view on EDGAR
- - James M. Frates view on EDGAR
- - Geno J. Germano view on EDGAR
- - George Golumbeski view on EDGAR
- - Elizabeth A. Barrett view on EDGAR
- - Jessica Federer view on EDGAR
- - Barry E. Greene view on EDGAR
- - Michael C. Quirk view on EDGAR
- - Christopher Benecchi view on EDGAR
- - Gregory L. Shiferman view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where SAGE's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track SAGE insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
